Da-vinci sp Versus xi Thyroid Surgery

One year comparative analysis between SPRA* versus BABA** thyroid surgery. * SPRA: da-Vinci SP Robotic Areolar approach thyroid surgery

** BABA: da-Vinci Xi robotic Bilateral. Axillary Breast Approach thyroid surgery

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thyroid Cancer Endocrine Gland Neoplasms Endocrine System Diseases Head and Neck Neoplasms Neoplasms Neoplasms by Site Thyroid Diseases Thyroid Neoplasms Thyroid Nodule

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Inha University Hospital

Incheon, 22332, South Korea

About this study

Study design: retrospective data analysis Study period: December 2022 to December 2023 Candidate: Patients who received robot thyroid surgery during study period Numbers of candidates: total of 270 patients Group : SPRA (n=111) versus BABA (n=159) Statistic analysis: t-test for continuous variable, fisher's exact test for categorical variable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who received robot thyroid surgery in our institution
Retrospective review

Exclusion criteria

Treatment and study plan

robot surgery device

Device

SPRA used da-Vinci SP system (SPRA) BABA used da-Vinci Xi system (BABA)

Primary outcomes

Total operation time (minutes)

Time frame: on the surgery day (1 day)

Time for spending total surgery

Secondary outcomes

Hospital stay days after surgery

Time frame: after the surgery day (up to 2 weeks)

Hospital admission days after surgery

Sponsors and collaborators

Lead sponsor

Inha University Hospital

Other

Registry information

Official study title

One-year Clinical Experiences of Single-port and Multi-port Robotic Thyroid Surgery in Single Institution

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2024
First posted: Aug 27, 2024
Registry last updated: Aug 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed